Label | TTM Value / Value | Unit | Change % |
---|---|---|---|
Current Ratio | 1.25 | % | -89.2% |
Debt-to-equity | -101 | % | +3.21% |
Return On Equity | -2.59 | % | +56.6% |
Return On Assets | 0.93 | % | -9.72% |
Label | TTM Value / Value | Unit | Change % |
---|---|---|---|
Entity Common Stock, Shares Outstanding | 3.68M | shares | -17% |
Common Stock, Shares, Outstanding | 2.35M | shares | 0% |
Entity Public Float | 42.2M | USD | |
Common Stock, Value, Issued | 235 | USD | 0% |
Weighted Average Number of Shares Outstanding, Basic | 3.68M | shares | -17% |
Weighted Average Number of Shares Outstanding, Diluted | 3.68M | shares | -17% |
Label | TTM Value / Value | Unit | Change % |
---|---|---|---|
General and Administrative Expense | 728K | USD | -29.3% |
Operating Income (Loss) | -788K | USD | +27.7% |
Nonoperating Income (Expense) | 936K | USD | -29.3% |
Net Income (Loss) Attributable to Parent | 148K | USD | -36.8% |
Earnings Per Share, Basic | 0.06 | USD/shares | +100% |
Earnings Per Share, Diluted | 0.06 | USD/shares |
Label | TTM Value / Value | Unit | Change % |
---|---|---|---|
Cash and Cash Equivalents, at Carrying Value | 6.1K | USD | +93.7% |
Assets, Current | 44.5K | USD | -1.19% |
Assets | 16.6M | USD | -29.6% |
Liabilities, Current | 3.56M | USD | +75.1% |
Liabilities | 6.29M | USD | +32.1% |
Retained Earnings (Accumulated Deficit) | -6.25M | USD | -32.4% |
Stockholders' Equity Attributable to Parent | -6.25M | USD | -32.4% |
Liabilities and Equity | 16.6M | USD | -29.6% |
Label | TTM Value / Value | Unit | Change % |
---|---|---|---|
Net Cash Provided by (Used in) Operating Activities | -88.4K | USD | +55.4% |
Net Cash Provided by (Used in) Financing Activities | 243K | USD | -53.4% |
Net Cash Provided by (Used in) Investing Activities | -150K | USD | +58.3% |
Common Stock, Shares Authorized | 500M | shares | 0% |
Common Stock, Shares, Issued | 2.35M | shares | 0% |
Common Stock, Par or Stated Value Per Share | 0 | USD/shares | 0% |
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect | 5.12K | USD | |
Unrecognized Tax Benefits | 0 | USD |